Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder
Clinical trial NCT04466345 · COMPLETED
Trial details
- NCT number
- NCT04466345
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2024-12-27
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.